A Study of CS1001 in Subjects With Relapsed or Refractory Classical Hodgkin Lymphoma
Clinical trial NCT03505996 · COMPLETED
Trial details
- NCT number
- NCT03505996
- Sponsor
- CStone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-22
- Primary completion
- 2020-02-19
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.